Bipolar disorder

...ba href=/bipolar disorder/a/b, said Mr Burns made a sexual advance to her.

She claimed he said: “You want to touch something, touch this”, before sticking her hand down his jeans.

Ms Berkin was convicted and fined $300 and ordered to pay back the missing $300.

No conviction was recorded.

EMAIL STORY PRINT STORY Back to top ASX Stock Lookup Enter an ASX Code or Part company name Max to find 10 50 100 All Today's Weather Visit an Australian APN Newspaper - Select a Newspaper - Bundaberg News-Mail Byron Shire News Coffs Harbour Advocate Fraser Coast Chronicle Gladstone Observer Gold Coast Mail Grafton Daily Examiner Ipswich Queensland Times Lismore Northern Star Mackay Daily Mercury Noosa News Rockhampton Morning Bulletin Sunshine Coast Daily The Gympie Times Toowoomba Chronicle Tweed Daily News Warwick Daily News Visit a New Zealand APN Newspaper - Select a Newspaper - Bay of Plenty Times Hawkes Bay Today New Zealand Herald Rotorua Daily Post The Star Wairarapa Times-Age Wanganui Chronicle Whangarei Northern Advocate Contact Us Terms of Use © APN News & Media Ltd 2006.

Unauthorised reproduction is prohibited under the laws of Australia and by international treaty.

...

... ScienceDaily: Ped Med: ADHD treatments raise questions @import "/styles/tabs.css"; Show menu RSS feeds | Free newsletter Breaking News Updated every 15 minutes (powered by UPI) All NewsTop NewsBusinessScienceEntertainmentSportsQuirksTopics Arts, Culture And Entertainment Crime, Law And Justice Disaster And Accident Economy, Business And Finance Education Environmental Issue Health Human Interest Labour Lifestyle And Leisure Politics Religion And Belief Science And Technology Social Issue Sport Unrest, Conflicts And War WeatherPed Med: ADHD treatments raise questionsBy LIDIA WASOWICZSAN FRANCISCO, March 24 (UPI) - While no causative connection has been proven, reports of a small number of children medicated for attention-deficit/hyperactivity disorder seeing snakes or suffering strokes have prompted two federal advisory panels to recommend that parents and physicians be alerted to the potential risks.

In the latest non-binding move, a Food and Drug Administration pediatric committee Wednesday urged a beefed-up warning on the drugs' labels, though not the direst type referred to as a "black box." That's the kind an FDA-commissioned group of experts focusing on safety had favored in February after reviewing cases of sudden death, heart attacks, strokes and other cardiac problems experienced by a tiny fraction of ADHD patients who were taking the medicines and who apparently had underlying cardiac irregularities.

The specialists meeting Wednesday took the softer approach i...

...ba href=/bipolar disorder/a/b.

People with bipolar mania may experience high levels of energy, unrealistic thoughts or ideas, and reckless and/or impulsive behavior.

Of the more than three million Americans believed to suffer from ba href=/bipolar disorder/a/b, two-thirds are often under-diagnosed and under-treated, according to the National Alliance for the Mentally Ill, the leading advocacy organization for people with mental illness.(3)RISPERDAL has been marketed in tablet form in the United States since 1994.

It is available as a standard, oral tablet in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg doses; a quick-dissolving tablet (RISPERDAL M-TAB) in 0.5 mg, 1 mg and 2 mg doses (new 3 mg and 4 mg doses are now available); and an oral solution in a 1.0 mg/mL dose.

RISPERDAL CONSTA® (risperidone) Long- Acting Injection is also available in 25 mg, 37.5 mg and 50 mg strengths, and is given by intramuscular injection every two weeks.RISPERDAL® is indicated for the treatment of schizophrenia and for the short term treatment of bipolar mania in acute manic or mixed episodes of Bipolar I Disorder (manic depression).

As with all other psychotropic medications, RISPERDAL® is associated with side effects.Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo.

Neither RISPERDAL or RISPERDAL® CONSTA® is approved for the treatment of patients with Dementia-Related Psychosis.The most common side effects that occurred with ...